BriaCell Therapeutics Corp. (BCTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.89M | -8.11M | -10.69M | -11.2M | -10.11M | -8.55M | -9.48M | -5.65M | -6.78M | -10.01M | -10.23M | -14.7M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 61.48% | 5.17% | -12.72% | -98.14% | -49.04% | 14.54% | 7.27% | 61.53% | 5.54% | -87.22% | -117.64% | -341.91% |
| Net Income | -7.24M | -4.2M | -11.37M | -11.06M | -8.72M | -9.06M | -7.91M | -1.67M | 2.31M | -15.27M | 8.07M | -3.23M |
| Depreciation & Amortization | 33.01K | 16.33K | 36.99K | 36.43K | 37.92K | 38.4K | 36.35K | 99.74K | 5.14K | 5.16K | 5.13K | 5.1K |
| Stock-Based Compensation | 432.21K | 580.54K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.91M | -3.22M | 330.88K | -755.68K | 87.81K | -697.92K | 1.27M | -5.89M | -14.1M | 2.76M | -18.55M | -6.17M |
| Working Capital Changes | 966.15K | -1.28M | 315.87K | 572.51K | -1.51M | 1.17M | -2.87M | 1.81M | 5.01M | 2.5M | 242.53K | -5.3M |
| Change in Receivables | -133.38K | -1.1M | 1.23M | -2.06K | 18.19K | 1K | 1M | -1.01M | 20.03K | -11.83K | -3.41K | -5.32K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -927.76K | 0 |
| Cash from Investing | -16.11M | 7.41M | -104.06K | -10.25M | -147.9K | -107.97K | -102.28K | -625.77K | -301.8K | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -624.21K | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -324.88K | 7.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -504.75K | 28.38M | 0 | 18.68M | 20.7M | 7.7M | 16.31M | 6.04M | 0 | 0 | 0 | 5.37M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 38.73M | 0 | 18.68M | 20.7M | 7.7M | 16.31M | 6.04M | 0 | 0 | 0 | 5.37M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -116 |
| Other Financing | -504.75K | -10.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -23.02M | 27.01M | -10.87M | -2.76M | 10.33M | -1.17M | 6.86M | -98K | -7.21M | -10M | -10.38M | -9.23M |
| Free Cash Flow | -3.89M | -8.11M | -10.69M | -11.2M | -10.11M | -8.55M | -9.48M | -6.28M | -6.78M | -10.01M | -10.23M | -14.7M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 61.48% | 5.17% | -12.72% | -78.45% | -49.04% | 14.54% | 7.27% | 57.28% | 5.54% | -87.22% | -117.64% | -341.91% |
| FCF per Share | -0.54 | -2.89 | -5.67 | -5.95 | -5.41 | -3.17 | -5.34 | -5.22 | -6.36 | -9.39 | -9.20 | -13.79 |
| FCF Conversion (FCF/Net Income) | 0.54x | 1.10x | 0.93x | 1.01x | 1.19x | 0.92x | 1.17x | 3.35x | -2.89x | 0.66x | -1.24x | 4.55x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |